- Med BioGene's 2012 Revenues Drop to Zero, as it Awaits Launch of NSCLC Test
April 9, 2013 / GenomeWeb Daily News
- In Brief This Week: SynapDx; Quidel; Med BioGene, Precision Therapeutics; CellHealth Institute
March 29, 2013 / GenomeWeb Daily News
- Dx Focus: Precision Therapeutics, Med BioGene LungExpress Dx; Hologic Prodesse ProGastro SSCS
January 24, 2013 / PCR Insider
- Targeting Mid-Year LungExpress Dx Launch, Precision Readies Sales Force, Focuses on Reimbursement
January 23, 2013 / Pharmacogenomics Reporter
- Med BioGene Amends Licensing Deal with Precision; Updates Litigation Status
October 3, 2012 / GenomeWeb Daily News